Pfizer Goodwill and Intangible Assets 2010-2025 | PFE

Pfizer goodwill and intangible assets for the quarter ending March 31, 2025 were $122.420B, a 7.35% decline year-over-year.

  • Pfizer goodwill and intangible assets for 2024 were $123.938B, a 6.59% decline from 2023.
  • Pfizer goodwill and intangible assets for 2023 were $132.683B, a 40.04% increase from 2022.
  • Pfizer goodwill and intangible assets for 2022 were $94.745B, a 27.42% increase from 2021.

Pfizer Goodwill and Intangible Assets 2010-2025 | PFE

  • Pfizer goodwill and intangible assets for 2024 were $123.938B, a 6.59% decline from 2023.
  • Pfizer goodwill and intangible assets for 2023 were $132.683B, a 40.04% increase from 2022.
  • Pfizer goodwill and intangible assets for 2022 were $94.745B, a 27.42% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B